Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Carlson, Jonathan M"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells.
Autorzy:
Ramsuran V; Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Naranbhai V; Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.; Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Horowitz A; Department of Oncological Sciences, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Qi Y; Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Martin MP; Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Yuki Y; Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Gao X; Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Walker-Sperling V; Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
Del Prete GQ; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Schneider DK; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Lifson JD; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Fellay J; School of Life Sciences, École Polytechnique Fédérale de Lausanne, and Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Deeks SG; Department of Medicine University of California, San Francisco, CA 94143, USA.
Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143, USA.
Goedert JJ; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.
Wolinsky SM; Division of Infectious Diseases, The Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Michael NL; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Kirk GD; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Buchbinder S; Department of Medicine University of California, San Francisco, CA 94143, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA 94143, USA.; San Francisco Department of Public Health, HIV Research Section, San Francisco, CA 94102, USA.
Haas D; Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Ndung'u T; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; African Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Max Planck Institute for Infection Biology, Berlin, Germany.
Goulder P; African Health Research Institute, Durban, South Africa.; Department of Paediatrics, University of Oxford, Oxford, UK.
Parham P; Departments of Structural Biology and Microbiology and Immunology, Stanford University, Stanford, CA 94305, USA.
Walker BD; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; African Health Research Institute, Durban, South Africa.; Institute for Medical and Engineering Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Carlson JM; Microsoft Research, Redmond, WA 98052, USA.
Carrington M; Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. .; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2018 Jan 05; Vol. 359 (6371), pp. 86-90. Date of Electronic Publication: 2018 Jan 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV/*immunology
HIV Infections/*immunology
HLA Antigens/*metabolism
Killer Cells, Natural/*immunology
NK Cell Lectin-Like Receptor Subfamily C/*metabolism
Alleles ; CD4 Lymphocyte Count ; Cohort Studies ; HIV Infections/drug therapy ; HIV Infections/genetics ; HLA Antigens/genetics ; Humans ; Ligands ; NK Cell Lectin-Like Receptor Subfamily C/antagonists & inhibitors ; NK Cell Lectin-Like Receptor Subfamily C/genetics ; Protein Sorting Signals ; Viremia/immunology
Czasopismo naukowe
Tytuł:
HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck.
Autorzy:
Carlson JM; Microsoft Research, Redmond, WA 98052, USA. carlson@microsoft.com .
Schaefer M; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Monaco DC; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Batorsky R; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02114, USA.
Claiborne DT; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Prince J; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Deymier MJ; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Ende ZS; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
Klatt NR; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
DeZiel CE; Microsoft Research, Redmond, WA 98052, USA.
Lin TH; Microsoft Research, Redmond, WA 98052, USA.
Peng J; Microsoft Research, Redmond, WA 98052, USA.
Seese AM; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02114, USA.
Shapiro R; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Frater J; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 7BN, UK. National Institute of Health Research, Oxford Biomedical Research Centre, Oxford OX3 7LE, UK. Oxford Martin School, University of Oxford, Oxford OX1 3BD, UK.
Ndung'u T; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02114, USA. HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4013, South Africa. KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa. Max Planck Institute for Infection Biology, D-10117 Berlin, Germany.
Tang J; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Goepfert P; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Gilmour J; International AIDS Vaccine Initiative, London SW10 9NH, UK. Imperial College of Science Technology and Medicine, London SW10 9NH, UK.
Price MA; International AIDS Vaccine Initiative, San Francisco, CA 94105, USA. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94105, USA.
Kilembe W; Rwanda-Zambia HIV Research Group: Zambia-Emory HIV Research Project, Lusaka, Zambia.
Heckerman D; Microsoft Research, Los Angeles, CA 98117, USA.
Goulder PJ; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban 4013, South Africa. Department of Paediatrics, University of Oxford, Oxford OX1 3SY, UK.
Allen TM; Rwanda-Zambia HIV Research Group: Zambia-Emory HIV Research Project, Lusaka, Zambia. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA. Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Allen S; International AIDS Vaccine Initiative, San Francisco, CA 94105, USA. Microsoft Research, Los Angeles, CA 98117, USA. Department of Paediatrics, University of Oxford, Oxford OX1 3SY, UK.
Hunter E; Emory Vaccine Center at Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA. Rwanda-Zambia HIV Research Group: Zambia-Emory HIV Research Project, Lusaka, Zambia. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA. carlson@microsoft.com .
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2014 Jul 11; Vol. 345 (6193), pp. 1254031. Date of Electronic Publication: 2014 Jul 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Heterosexuality*
Selection, Genetic*
HIV Infections/*transmission
HIV-1/*genetics
Amino Acid Sequence ; Consensus Sequence ; DNA Mutational Analysis ; Disease Transmission, Infectious/statistics & numerical data ; Female ; High-Throughput Nucleotide Sequencing ; Human Immunodeficiency Virus Proteins/genetics ; Humans ; Male ; Models, Statistical ; Molecular Sequence Data ; Point Mutation ; Risk Factors ; Viral Load
Czasopismo naukowe
Tytuł:
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Autorzy:
Pereyra F
Jia X
McLaren PJ
Telenti A
de Bakker PI
Walker BD
Ripke S
Brumme CJ
Pulit SL
Carrington M
Kadie CM
Carlson JM
Heckerman D
Graham RR
Plenge RM
Deeks SG
Gianniny L
Crawford G
Sullivan J
Gonzalez E
Davies L
Camargo A
Moore JM
Beattie N
Gupta S
Crenshaw A
Burtt NP
Guiducci C
Gupta N
Gao X
Qi Y
Yuki Y
Piechocka-Trocha A
Cutrell E
Rosenberg R
Moss KL
Lemay P
O'Leary J
Schaefer T
Verma P
Toth I
Block B
Baker B
Rothchild A
Lian J
Proudfoot J
Alvino DM
Vine S
Addo MM
Allen TM
Altfeld M
Henn MR
Le Gall S
Streeck H
Haas DW
Kuritzkes DR
Robbins GK
Shafer RW
Gulick RM
Shikuma CM
Haubrich R
Riddler S
Sax PE
Daar ES
Ribaudo HJ
Agan B
Agarwal S
Ahern RL
Allen BL
Altidor S
Altschuler EL
Ambardar S
Anastos K
Anderson B
Anderson V
Andrady U
Antoniskis D
Bangsberg D
Barbaro D
Barrie W
Bartczak J
Barton S
Basden P
Basgoz N
Bazner S
Bellos NC
Benson AM
Berger J
Bernard NF
Bernard AM
Birch C
Bodner SJ
Bolan RK
Boudreaux ET
Bradley M
Braun JF
Brndjar JE
Brown SJ
Brown K
Brown ST
Burack J
Bush LM
Cafaro V
Campbell O
Campbell J
Carlson RH
Carmichael JK
Casey KK
Cavacuiti C
Celestin G
Chambers ST
Chez N
Chirch LM
Cimoch PJ
Cohen D
Cohn LE
Conway B
Cooper DA
Cornelson B
Cox DT
Cristofano MV
Cuchural G Jr
Czartoski JL
Dahman JM
Daly JS
Davis BT
Davis K
Davod SM
DeJesus E
Dietz CA
Dunham E
Dunn ME
Ellerin TB
Eron JJ
Fangman JJ
Farel CE
Ferlazzo H
Fidler S
Fleenor-Ford A
Frankel R
Freedberg KA
French NK
Fuchs JD
Fuller JD
Gaberman J
Gallant JE
Gandhi RT
Garcia E
Garmon D
Gathe JC Jr
Gaultier CR
Gebre W
Gilman FD
Gilson I
Goepfert PA
Gottlieb MS
Goulston C
Groger RK
Gurley TD
Haber S
Hardwicke R
Hardy WD
Harrigan PR
Hawkins TN
Heath S
Hecht FM
Henry WK
Hladek M
Hoffman RP
Horton JM
Hsu RK
Huhn GD
Hunt P
Hupert MJ
Illeman ML
Jaeger H
Jellinger RM
John M
Johnson JA
Johnson KL
Johnson H
Johnson K
Joly J
Jordan WC
Kauffman CA
Khanlou H
Killian RK
Kim AY
Kim DD
Kinder CA
Kirchner JT
Kogelman L
Kojic EM
Korthuis PT
Kurisu W
Kwon DS
LaMar M
Lampiris H
Lanzafame M
Lederman MM
Lee DM
Lee JM
Lee MJ
Lee ET
Lemoine J
Levy JA
Llibre JM
Liguori MA
Little SJ
Liu AY
Lopez AJ
Loutfy MR
Loy D
Mohammed DY
Man A
Mansour MK
Marconi VC
Markowitz M
Marques R
Martin JN
Martin HL Jr
Mayer KH
McElrath MJ
McGhee TA
McGovern BH
McGowan K
McIntyre D
Mcleod GX
Menezes P
Mesa G
Metroka CE
Meyer-Olson D
Miller AO
Montgomery K
Mounzer KC
Nagami EH
Nagin I
Nahass RG
Nelson MO
Nielsen C
Norene DL
O'Connor DH
Ojikutu BO
Okulicz J
Oladehin OO
Oldfield EC 3rd
Olender SA
Ostrowski M
Owen WF Jr
Pae E
Parsonnet J
Pavlatos AM
Perlmutter AM
Pierce MN
Pincus JM
Pisani L
Price LJ
Proia L
Prokesch RC
Pujet HC
Ramgopal M
Rathod A
Rausch M
Ravishankar J
Rhame FS
Richards CS
Richman DD
Rodes B
Rodriguez M
Rose RC 3rd
Rosenberg ES
Rosenthal D
Ross PE
Rubin DS
Rumbaugh E
Saenz L
Salvaggio MR
Sanchez WC
Sanjana VM
Santiago S
Schmidt W
Schuitemaker H
Sestak PM
Shalit P
Shay W
Shirvani VN
Silebi VI
Sizemore JM Jr
Skolnik PR
Sokol-Anderson M
Sosman JM
Stabile P
Stapleton JT
Starrett S
Stein F
Stellbrink HJ
Sterman FL
Stone VE
Stone DR
Tambussi G
Taplitz RA
Tedaldi EM
Telenti A
Theisen W
Torres R
Tosiello L
Tremblay C
Tribble MA
Trinh PD
Tsao A
Ueda P
Vaccaro A
Valadas E
Vanig TJ
Vecino I
Vega VM
Veikley W
Wade BH
Walworth C
Wanidworanun C
Ward DJ
Warner DA
Weber RD
Webster D
Weis S
Wheeler DA
White DJ
Wilkins E
Winston A
Wlodaver CG
van't Wout A
Wright DP
Yang OO
Yurdin DL
Zabukovic BW
Zachary KC
Zeeman B
Zhao M
Pokaż więcej
Corporate Authors:
International HIV Controllers Study; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology (MIT) and Harvard, Boston, MA, USA.
Źródło:
Science (New York, N.Y.) [Science] 2010 Dec 10; Vol. 330 (6010), pp. 1551-7. Date of Electronic Publication: 2010 Nov 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigen Presentation*
Genes, MHC Class I*
HIV-1*/immunology
HIV Infections/*genetics
HIV Infections/*immunology
HLA-B Antigens/*genetics
Black or African American/genetics ; Alleles ; Amino Acids/physiology ; CD8-Positive T-Lymphocytes/immunology ; Cohort Studies ; Disease Progression ; Genome-Wide Association Study ; HIV Antigens/immunology ; HIV Infections/ethnology ; HIV Infections/virology ; HIV Long-Term Survivors ; HLA-A Antigens/chemistry ; HLA-A Antigens/genetics ; HLA-A Antigens/immunology ; HLA-A Antigens/metabolism ; HLA-B Antigens/chemistry ; HLA-B Antigens/immunology ; HLA-B Antigens/metabolism ; HLA-C Antigens/chemistry ; HLA-C Antigens/genetics ; HLA-C Antigens/immunology ; HLA-C Antigens/metabolism ; Haplotypes ; Hispanic or Latino/genetics ; Humans ; Immunity, Innate ; Logistic Models ; Models, Molecular ; Polymorphism, Single Nucleotide ; Protein Conformation ; Viral Load ; White People/genetics
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies